Submitted by: Submitted by marketresearchri
Views: 12
Words: 1047
Pages: 5
Category: Business and Industry
Date Submitted: 05/10/2016 10:37 PM
Acid Sphingomyelinase Deficiency (Niemann-Pick
Disease) Type C Market Share Pipeline Review, H2 2015
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline Review, H2 2015
Summary
Global Markets Direct's, 'Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C - Pipeline
Review, H2 2015', provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick
Disease) Type C's therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Acid
Sphingomyelinase Deficiency (Niemann-Pick Disease) Type C, complete with comparative analysis at
various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates, and featured news and press
releases. It also reviews key players involved in the therapeutic development for Acid Sphingomyelinase
Deficiency (Niemann-Pick Disease) Type C and special features on late-stage and discontinued projects.
Access Full Report With TOC @ http://www.radiantinsights.com/research/acid-sphingomyelinasedeficiency-niemann-pick-disease-type-c-pipeline-review-h2-2015
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally, processes including live news &
deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent...